المؤلفون: Ortiz-Seller A; Unit of Paediatric Ophthalmology and Strabismus, Oftalvist Clinic, Valencia, Spain., Martorell P; Department of Chemical and Nuclear Engineering, Universitat Politècnica de València, Spain., Barranco H; Unit of Paediatric Ophthalmology and Strabismus, La Fe University and Polytechnic Hospital of Valencia, Spain., Pascual-Camps I; Unit of Paediatric Ophthalmology and Strabismus, La Fe University and Polytechnic Hospital of Valencia, Spain., Morcillo E; Health Research Institute (INCLIVA) of the Clinic University Hospital of Valencia and Department of Pharmacology, Faculty of Medicine, Universitat de València, Spain., Ortiz JL; Department of Pharmacology, Faculty of Medicine, Universitat de València, Spain. Electronic address: jose.l.ortiz@uv.es.

المصدر: Survey of ophthalmology [Surv Ophthalmol] 2024 Jul-Aug; Vol. 69 (4), pp. 585-605. Date of Electronic Publication: 2024 Mar 01.

نوع المنشور: Journal Article; Meta-Analysis; Comparative Study; Review

بيانات الدورية: Publisher: Elsevier Science Country of Publication: United States NLM ID: 0404551 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-3304 (Electronic) Linking ISSN: 00396257 NLM ISO Abbreviation: Surv Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Retinopathy of Prematurity*/drug therapy , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/therapeutic use , Intravitreal Injections* , Receptors, Vascular Endothelial Growth Factor*/administration & dosage , Network Meta-Analysis* , Bevacizumab*/administration & dosage , Bevacizumab*/therapeutic use , Vascular Endothelial Growth Factor A*/antagonists & inhibitors , Recombinant Fusion Proteins*/administration & dosage , Recombinant Fusion Proteins*/therapeutic use , Ranibizumab*/administration & dosage , Ranibizumab*/therapeutic use , Laser Coagulation*/methods, Humans ; Infant, Newborn

المؤلفون: Padhi TR; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, India., Bhunia S; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, India., Shah M; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, India., Sahu S; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, India., Das T; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Kallam Anji Reddy Campus), Hyderabad, India., Bhusal U; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, India., Singh A; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, India., Samantaray B; Department of Ophthalmology, SCB Medical College, Cuttack, India., Patro K; Department of Ophthalmology, SCB Medical College, Cuttack, India., Devi S; Department of Ophthalmology, MKCG Medical College, Berhampur, India., Routray D; Department of Community Medicine, Dharanidhar Medical College Hospital, Keonjhar, India; and., Mohamed A; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Mithu Tulsi Chanrai Campus), Bhubaneswar, India., Pradhan L; Department of Paediatrics, Capital Hospital, Bhubaneswar, India., Jalali S; Anant Bajaj Retina Institute, L V Prasad Eye Institute (Kallam Anji Reddy Campus), Hyderabad, India.

المصدر: Retina (Philadelphia, Pa.) [Retina] 2024 Jun 01; Vol. 44 (6), pp. 1073-1082.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Retinopathy of Prematurity*/surgery , Retinopathy of Prematurity*/drug therapy , Retinopathy of Prematurity*/therapy , Retinopathy of Prematurity*/diagnosis , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/administration & dosage , Intravitreal Injections* , Gestational Age* , Vascular Endothelial Growth Factor A*/antagonists & inhibitors , Laser Coagulation*/methods, Humans ; Retrospective Studies ; Female ; Male ; India/epidemiology ; Infant, Newborn ; Prospective Studies ; Follow-Up Studies ; Vitrectomy/methods ; Treatment Outcome ; Bevacizumab/therapeutic use ; Bevacizumab/administration & dosage ; Birth Weight ; Infant ; Visual Acuity

المؤلفون: Ng WL; Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok, 10700, Thailand., Trinavarat A; Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok, 10700, Thailand., Atchaneeyasakul LO; Department of Ophthalmology, Faculty of Medicine Siriraj Hospital, Mahidol University, 2 Wanglang Road, Bangkok, 10700, Thailand. atchanee@hotmail.com.

المصدر: BMC pediatrics [BMC Pediatr] 2024 May 04; Vol. 24 (1), pp. 301. Date of Electronic Publication: 2024 May 04.

نوع المنشور: Journal Article; Case Reports

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967804 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2431 (Electronic) Linking ISSN: 14712431 NLM ISO Abbreviation: BMC Pediatr Subsets: MEDLINE

مواضيع طبية MeSH: Retinopathy of Prematurity* , Bevacizumab*/therapeutic use , Bevacizumab*/administration & dosage , Intravitreal Injections* , Angiogenesis Inhibitors*/therapeutic use , Angiogenesis Inhibitors*/administration & dosage , Laser Coagulation*/methods , Retinal Neovascularization*/etiology , Retinal Neovascularization*/drug therapy , Fluorescein Angiography*, Humans ; Infant, Newborn ; Female ; Antibodies, Monoclonal, Humanized/therapeutic use ; Antibodies, Monoclonal, Humanized/administration & dosage ; Combined Modality Therapy

المؤلفون: Dupas B; Service d'ophtalmologie, Hôpital Lariboisière, AP-HP Nord, Université Paris Cité, Paris, France. dupas@coss.paris.; FRCRnet/FCRIN Network, Paris, France. dupas@coss.paris., Castro-Farias D; Hopital Des Quinze-Vingts, Centre d'Investigation Clinique 1423, INSERM, Paris, France., Girmens JF; Hopital Des Quinze-Vingts, Centre d'Investigation Clinique 1423, INSERM, Paris, France., Eginay A; Service d'ophtalmologie, Hôpital Lariboisière, AP-HP Nord, Université Paris Cité, Paris, France., Couturier A; Service d'ophtalmologie, Hôpital Lariboisière, AP-HP Nord, Université Paris Cité, Paris, France., Villeroy F; Service d'ophtalmologie, CHU de La Réunion, Hôpital Félix Guyon, Saint-Denis, France., Delyfer MN; Service d'ophtalmologie, CHU de Bordeaux - Hôpital Pellegrin, Bordeaux, France.; FRCRnet/FCRIN Network, Bordeaux, France., Creuzot-Garcher C; Service d'Ophtalmologie, CHU de Dijon - Hopital François Miterrand, Dijon, France.; FRCRnet/FCRIN Network, Dijon, France., Giocanti-Auregan A; Service d'Ophtalmologie, Hôpital Avicenne, Université Sorbonne Paris Nord, Bobigny, France., Béral L; Service d'Ophtalmologie, CHU de Pointe-À-Pitre, Les Abymes, France., Arndt C; Service d'Ophtalmologie, CHU de Reims, Reims, France., Mesnard C; Service d'Ophtalmologie, CHU de Martinique, Fort-de-France, France., Vicaut E; URC Lariboisière-St Louis, Hôpital Fernand Widal, AP-HP Nord, Université Paris Cité, Paris, France., Chaumet-Riffaud P; Hopital Des Quinze-Vingts, Centre d'Investigation Clinique 1423, INSERM, Paris, France., Durand-Zaleski I; DRCI URCEco Et Hôpital Henri Mondor, AP-HP, Université Paris Est Créteil, Paris, France., Paques M; FRCRnet/FCRIN Network, Paris, France.; Hopital Des Quinze-Vingts, Centre d'Investigation Clinique 1423, INSERM, Paris, France.

المصدر: Trials [Trials] 2024 Apr 22; Vol. 25 (1), pp. 273. Date of Electronic Publication: 2024 Apr 22.

نوع المنشور: Journal Article; Clinical Trial Protocol; Multicenter Study

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium: Internet ISSN: 1745-6215 (Electronic) Linking ISSN: 17456215 NLM ISO Abbreviation: Trials Subsets: MEDLINE

مواضيع طبية MeSH: Macular Edema*/etiology , Macular Edema*/drug therapy , Macular Edema*/surgery , Retinal Vein Occlusion*/drug therapy , Retinal Vein Occlusion*/complications , Diabetic Retinopathy*/drug therapy , Laser Coagulation*/methods , Vascular Endothelial Growth Factor A*/antagonists & inhibitors , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/adverse effects , Angiogenesis Inhibitors*/therapeutic use , Visual Acuity*, Humans ; France ; Treatment Outcome ; Multicenter Studies as Topic ; Intravitreal Injections ; Time Factors ; Equivalence Trials as Topic ; Combined Modality Therapy

المؤلفون: Walton M; Centre for Reviews and Dissemination, University of York, UK. Electronic address: matthew.walton@york.ac.uk., Bojke L; Centre for Health Economics, University of York, UK., Simmonds M; Centre for Reviews and Dissemination, University of York, UK., Walker R; Centre for Reviews and Dissemination, University of York, UK., Llewellyn A; Centre for Reviews and Dissemination, University of York, UK., Fulbright H; Centre for Reviews and Dissemination, University of York, UK., Dias S; Centre for Reviews and Dissemination, University of York, UK., Stewart LA; Centre for Reviews and Dissemination, University of York, UK., Rush T; Patient representative., Steel DH; Biosciences Institute, Newcastle University, UK., Lawrenson JG; Department of Optometry and Visual Sciences, City, University of London, UK., Peto T; Centre for Public Health, Queen's University Belfast, UK., Hodgson R; Centre for Reviews and Dissemination, University of York, UK.

المصدر: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research [Value Health] 2024 Jul; Vol. 27 (7), pp. 907-917. Date of Electronic Publication: 2024 Mar 26.

نوع المنشور: Journal Article; Comparative Study

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 100883818 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1524-4733 (Electronic) Linking ISSN: 10983015 NLM ISO Abbreviation: Value Health Subsets: MEDLINE

مواضيع طبية MeSH: Diabetic Retinopathy*/drug therapy , Diabetic Retinopathy*/economics , Diabetic Retinopathy*/therapy , Diabetic Retinopathy*/surgery , Cost-Benefit Analysis* , Angiogenesis Inhibitors*/economics , Angiogenesis Inhibitors*/therapeutic use , Quality-Adjusted Life Years* , Vascular Endothelial Growth Factor A*/antagonists & inhibitors, Humans ; United Kingdom ; Visual Acuity ; Light Coagulation/economics ; Light Coagulation/methods ; Models, Economic ; Middle Aged ; Treatment Outcome ; Laser Coagulation/economics ; Laser Coagulation/methods ; Male ; Female ; Macular Edema/drug therapy ; Macular Edema/economics ; Macular Edema/therapy ; Cost-Effectiveness Analysis

المؤلفون: Pfeil JM; Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany., Barth T; Department of Ophthalmology, University of Regensburg, Regensburg, Germany., Lagrèze WA; Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany., Lorenz B; Department of Ophthalmology, Justus-Liebig University Giessen, Giessen, Germany., Hufendiek K; University Eye Hospital, Hannover Medical School, Hannover, Germany., Liegl R; Department of Ophthalmology, University Medicine Bonn, Bonn, Germany., Breuss H; Department of Ophthalmology, HELIOS Klinikum Berlin-Buch, Berlin, Germany., Bemme S; Department of Ophthalmology, University Medical Center Goettingen, Goettingen, Germany., Aisenbrey S; Department of Ophthalmology, Vivantes Klinikum Neukoelln, Berlin, Germany., Glitz B; Department of Ophthalmology, University of Muenster Medical Center, Muenster, Germany., Süsskind D; University Eye Hospital, Eberhard Karls University of Tuebingen, Tuebingen, Germany., Gabel-Pfisterer A; Department of Ophthalmology, Klinikum Ernst von Bergmann, Potsdam, Germany., Skevas C; Department of Ophthalmology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Krohne TU; Department of Ophthalmology, Faculty of Medicine and University Hospital Cologne, University of Cologne, Cologne, Germany., Kakkassery V; Department of Ophthalmology, University of Luebeck, Luebeck, Germany., Bründer MC; Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany., Engelmann K; Department of Ophthalmology, Klinikum Chemnitz gGmbH, Chemnitz, Germany., Guthoff R; Department of Ophthalmology, Faculty of Medicine, University of Duesseldorf, Duesseldorf, Germany., Walter P; Department of Ophthalmology, University Hospital RWTH Aachen, Germany., Choritz L; Department of Ophthalmology, Otto von Guericke University, Magdeburg, Germany., Stahl A; Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany. Electronic address: andreas.stahl@med.uni-greifswald.de.

مؤلفون مشاركون: Retina.net ROP Registry Study Group

المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2024 Jun; Vol. 8 (6), pp. 579-589. Date of Electronic Publication: 2023 Dec 16.

نوع المنشور: Journal Article; Multicenter Study; Observational Study

بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE

مواضيع طبية MeSH: Retinopathy of Prematurity*/epidemiology , Retinopathy of Prematurity*/diagnosis , Registries* , Gestational Age* , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/therapeutic use, Humans ; Germany/epidemiology ; Infant, Newborn ; Male ; Female ; Laser Coagulation/methods ; Incidence ; Follow-Up Studies ; Intravitreal Injections ; Retrospective Studies ; Infant

المؤلفون: Lee YS; Department of Ophthalmology, New Taipei Municipal Tucheng Hospital, New Taipei City, Taiwan.; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan., Liu L; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan., Wang NK; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan.; Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York., Chen KJ; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan; and., Hwang YS; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan; and., Lai CC; College of Medicine, Chang Gung University, Taoyuan, Taiwan; and.; Department of Ophthalmology, Chang Gung Memorial Hospital, Keelung, Taiwan., Wu WC; Department of Ophthalmology, Chang Gung Memorial Hospital, Linkou, Taiwan.; College of Medicine, Chang Gung University, Taoyuan, Taiwan; and.

المصدر: Retina (Philadelphia, Pa.) [Retina] 2024 Jun 01; Vol. 44 (6), pp. 1063-1072.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 8309919 Publication Model: Print Cited Medium: Internet ISSN: 1539-2864 (Electronic) Linking ISSN: 0275004X NLM ISO Abbreviation: Retina Subsets: MEDLINE

مواضيع طبية MeSH: Choroid*/pathology , Choroid*/diagnostic imaging , Tomography, Optical Coherence*/methods , Retinopathy of Prematurity*/diagnosis , Retinopathy of Prematurity*/drug therapy , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/therapeutic use , Bevacizumab*/administration & dosage , Intravitreal Injections* , Gestational Age*, Humans ; Prospective Studies ; Male ; Female ; Child ; Follow-Up Studies ; Infant, Newborn ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Infant, Premature ; Laser Coagulation/methods ; Visual Acuity

المؤلفون: Stahl A; Department of Ophthalmology, University Medicine Greifswald, Greifswald, Germany., Azuma N; Department of Ophthalmology and Laboratory for Visual Science, National Centre for Child Health and Development, Tokyo, Japan.; Department of Developmental and Regenerative Biology, Medical Research Institute, Tokyo Medical and Dental University, Tokyo, Japan., Wu WC; Department of Ophthalmology, Linkou Chang Gung Memorial Hospital, and College of Medicine, Chang Gung University, Taoyuan, Taiwan., Lepore D; Department of Geriatrics and Neuroscience, Catholic University of the Sacred Heart, A. Gemelli Foundation IRCCS, Rome, Italy., Sukgen E; Department of Ophthalmology, Health Science University, Adana City Training and Research Hospital, Adana, Turkey., Nakanishi H; Research and Development Center for New Medical Frontiers, Department of Advanced Medicine, Division of Neonatal Intensive Care Medicine, Kitasato University School of Medicine, Sagamihara, Japan., Mazela J; Department of Neonatology, Poznan University of Medical Sciences, Poznan, Poland., Leal S; Bayer Consumer Care AG, Basel, Switzerland., Pieper A; Chrestos Concept GmbH & Co., Essen, Germany., Schlief S; Bayer AG, Berlin, Germany., Eissing T; Bayer AG, Leverkusen, Germany., Turner KC; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Zhao A; Regeneron Pharmaceuticals Inc., Tarrytown, NY, USA., Winkler J; OCCAMS, Amstelveen, the Netherlands., Höchel J; Bayer AG, Berlin, Germany. joachim.hoechel@bayer.com., Köfüncü E; Bayer AG, Berlin, Germany., Zimmermann T; Bayer AG, Berlin, Germany.

مؤلفون مشاركون: FIREFLEYE Study Group

المصدر: Eye (London, England) [Eye (Lond)] 2024 Jun; Vol. 38 (8), pp. 1444-1453. Date of Electronic Publication: 2024 Jan 10.

نوع المنشور: Journal Article; Clinical Trial, Phase III; Randomized Controlled Trial; Multicenter Study

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE

مواضيع طبية MeSH: Receptors, Vascular Endothelial Growth Factor*/administration & dosage , Retinopathy of Prematurity*/drug therapy , Recombinant Fusion Proteins*/administration & dosage , Intravitreal Injections* , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/pharmacokinetics , Angiogenesis Inhibitors*/adverse effects , Gestational Age* , Vascular Endothelial Growth Factor A*/antagonists & inhibitors , Infant, Premature*, Humans ; Infant, Newborn ; Male ; Female ; Laser Coagulation/methods

المؤلفون: Holmström G; Department of Surgical Sciences, Ophthalmology, Uppsala University, Uppsala, Sweden., Hellström A; Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden., Teär Fahnehjelm K; Department of Clinical Neuroscience, Section for Eye and Vision, Karolinska Institutet, Stockholm, Sweden.; St. Erik Eye Hospital, Stockholm, Sweden., Gränse L; Department of Clinical Sciences, Ophthalmology, Skane University Hospital, Lund University, Lund, Sweden., Sandgren Hochhard K; Department of Clinical Sciences, Ophthalmology, Umeå University, Umeå, Sweden., Sunnqvist B; Länssjukhuset Ryhov, Jönköping, Sweden., Tornqvist K; Department of Clinical Sciences, Ophthalmology, Skane University Hospital, Lund University, Lund, Sweden., Tsamadou D; Department of Ophthalmology, University Hospital, Örebro University, Örebro, Sweden., Wallin A; St. Erik Eye Hospital, Stockholm, Sweden., Larsson E; Department of Surgical Sciences, Ophthalmology, Uppsala University, Uppsala, Sweden.

المصدر: Acta ophthalmologica [Acta Ophthalmol] 2024 Jun; Vol. 102 (4), pp. 401-408. Date of Electronic Publication: 2023 Sep 12.

نوع المنشور: Journal Article; Multicenter Study

بيانات الدورية: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101468102 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1755-3768 (Electronic) Linking ISSN: 1755375X NLM ISO Abbreviation: Acta Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Retinopathy of Prematurity*/epidemiology , Retinopathy of Prematurity*/diagnosis , Retinopathy of Prematurity*/surgery , Retinopathy of Prematurity*/therapy , Gestational Age* , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/therapeutic use , Recurrence* , Vitrectomy*/methods, Humans ; Sweden/epidemiology ; Infant, Newborn ; Male ; Female ; Incidence ; Intravitreal Injections ; Laser Coagulation/methods ; Registries ; Retrospective Studies ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Follow-Up Studies ; Neonatal Screening/methods ; Hospitals/statistics & numerical data ; Infant

المؤلفون: Minturn R; Indiana University School of Medicine, Indianapolis, IN, USA., Hartigan K; Indiana University School of Medicine, Indianapolis, IN, USA., Vegunta S; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA., Boente C; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA., Golzarri-Arroyo L; Department of Epidemiology and Biostatistics, Indiana University School of Public Health Bloomington, Bloomington, IN, USA., Hynes E; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA., Laughlin E; Department of Pediatrics, Division of Neonatal- Perinatal Medicine, Indiana University School of Medicine, Indianapolis, IN, USA., Haider K; Department of Ophthalmology, Indiana University School of Medicine, Indianapolis, IN, USA. khaider@iupui.edu., Kua KL; Herman B Wells Center for Pediatric Research, Indianapolis, IN, USA. kkua@iu.edu.; Department of Pediatrics, Division of Neonatal- Perinatal Medicine, Indiana University School of Medicine, Indianapolis, IN, USA. kkua@iu.edu.

المصدر: BMC ophthalmology [BMC Ophthalmol] 2024 May 24; Vol. 24 (1), pp. 220. Date of Electronic Publication: 2024 May 24.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 100967802 Publication Model: Electronic Cited Medium: Internet ISSN: 1471-2415 (Electronic) Linking ISSN: 14712415 NLM ISO Abbreviation: BMC Ophthalmol Subsets: MEDLINE

مواضيع طبية MeSH: Retinopathy of Prematurity*/drug therapy , Retinopathy of Prematurity*/therapy , Retinopathy of Prematurity*/diagnosis , Bevacizumab*/administration & dosage , Bevacizumab*/therapeutic use , Angiogenesis Inhibitors*/administration & dosage , Angiogenesis Inhibitors*/therapeutic use , Intravitreal Injections* , Gestational Age* , Infant, Premature*, Humans ; Retrospective Studies ; Infant, Newborn ; Male ; Female ; Laser Coagulation/methods ; Oxygen Inhalation Therapy/methods ; Oxygen/therapeutic use ; Vascular Endothelial Growth Factor A/antagonists & inhibitors ; Treatment Outcome